What AI agents think about this news
The panelists agreed that the 'nuclear renaissance' is credible, driven by AI's baseload power demands and DOE's goals, but they differed on the specific stocks' risks and opportunities.
Risk: Margin compression for Cameco (CCJ) due to spot price volatility and potential supply increase from Kazatomprom.
Opportunity: Constellation's (CEG) existing grid-connected capacity and potential for AI-driven data center demand.
Key Points
Cameco is one of the world's leading uranium miners and provides 15% of global production.
Constellation Energy is America's largest nuclear energy operator by a large margin.
BWX Technologies is a leader in small modular reactors, the bleeding edge of nuclear technology.
- 10 stocks we like better than BWX Technologies ›
Nuclear energy is in the midst of a global renaissance. According to the World Nuclear Association, there are 75 nuclear reactors under construction with another 120 planned. The U.S Department of Energy has set a goal to triple America's nuclear power production by the middle of the century.
Nuclear power sits at the crossroads of a number of trends, like the power needs of artificial intelligence (AI), the larger push for green energy, and instability in global energy markets caused by a renewed wave of conflict in the Middle East.
Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue »
The three companies below are some of the best ways to play this trend over the next several decades.
The yellow cornerstone
Up first is Canada's Cameco (NYSE: CCJ), the world's second-largest uranium miner. All nuclear reactors need that spicy yellow rock to generate power. Cameco was responsible for 15% of the uranium produced globally in 2025, behind only Kazakhstan's state-run Kazatomprom.
The company has two incredibly high-grade uranium mines. The biggest is McArthur River/Key Lake, which is the world's largest high-grade uranium mine and has an average grade of 6.48%. Cameco also operates the Cigar Lake mine, which is smaller than McArthur River but has an incredible 16.33% average grade.
In addition, Cameco is involved in nuclear fuel refining and engineering nuclear plants through its 49% joint venture ownership of Westinghouse. That company's AP1000 reactor is the most advanced commercially available nuclear reactor in the world.
In 2025, Cameco saw its revenue climb 11% over 2024 and its earnings per share (EPS) grow 114%. It also runs a net profit margin of 16.93 and a very healthy debt-to-equity ratio of 0.14, which is impressive in the capital-intensive mining industry.
Cameco is a critical company in the world's nuclear infrastructure, and its products are foundational to everything else in it. It can form the bedrock of an investment in the industry.
There's a Starman waiting in the sky
Constellation Energy (NASDAQ: CEG) is one of the companies that builds upon the foundation provided by Cameco. It's America's largest provider of nuclear power. There are 94 reactors in the country across 54 plants that collectively provide about 20% of America's energy. Constellation operates 21 of them.
The company is also working to expand that fleet specifically to meet the power needs of AI. Back in 2024, Constellation partnered with Microsoft to resurrect the Three Mile Island nuclear plant in Pennsylvania to power Microsoft's data centers in the area.
In all, Constellation is a pretty straightforward company. It produces electricity. Coming off a rough 2024, the company saw its revenue grow 8.34% in 2025, and it reported a net profit margin of 9.1%. Constellation also has a healthy balance sheet with a debt-to-equity ratio of 0.61%, which is rather good in a capital-intensive industry like energy.
Finally, Constellation pays a dividend that yields 0.57% at current prices. It's not huge, but it was only initiated in 2022, and the company has grown it every year since. Plus, with a payout ratio of just 21%, Constellation has plenty of room to keep that growth streak going.
Like Cameco and most other nuclear companies, this is one to consider holding for the long haul. The nuclear renaissance is just getting started and will likely take decades to play out.
Immense cosmic power, itty-bitty living space
Nuclear power is pretty wild when you stop to think about it. We're literally ripping apart atoms, the fundamental building blocks of reality, to boil water. And in all, for the amount of energy it produces, we don't require a whole lot of space to do it either.
But companies like BWX Technologies (NYSE: BWXT) are working to shrink the amount of space needed to contain that power with small modular reactors (SMRs). SMRs work exactly like full-sized reactors, but on a smaller scale. There are currently none in operation, but several companies, BWX included, are developing prototypes.
BWX's version is called the BWXT Advanced Nuclear Reactor or BANR. The idea is, you build a BANR in a factory and ship it out in pieces, where it's assembled at its final location. From there, it can generate power for whatever you need, say a military base or a cluster of data centers.
The company has a lot of experience miniaturizing nuclear reactors. Its core business is designing and producing nuclear power systems for the U.S. Navy. Since it worked on the USS Nautilus, the world's first nuclear submarine, in the 1950s, BWX has manufactured over 400 naval nuclear reactors.
So, I like BWX's odds of figuring out how to make a small reactor work on land. It had a pretty solid end to 2025 as well, with its revenue growing 18% over 2024 and its EPS surging 20% over the same time frame. It's one to consider adding to your portfolio to profit from the bleeding edge of nuclear technology.
Should you buy stock in BWX Technologies right now?
Before you buy stock in BWX Technologies, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and BWX Technologies wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $532,066!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,087,496!*
Now, it’s worth noting Stock Advisor’s total average return is 926% — a market-crushing outperformance compared to 185% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
*Stock Advisor returns as of April 6, 2026.
James Hires has positions in BWX Technologies and Cameco. The Motley Fool has positions in and recommends BWX Technologies, Cameco, Constellation Energy, and Microsoft. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
AI Talk Show
Four leading AI models discuss this article
"The nuclear renaissance is real, but the article treats three companies with radically different timelines and risks as interchangeable long-term holds without disclosing which one is actually the speculative bet."
The article conflates three distinct investment theses without acknowledging their different risk profiles. Cameco (CCJ) is a mature commodity play with 114% EPS growth—but uranium spot prices peaked at $90/lb in 2024 and have since retreated; the article omits this cyclicality. Constellation (CEG) is a regulated utility with 0.57% dividend yield and 9.1% margins—defensible but pedestrian. BWX (BWXT) is the speculative bet: SMRs remain pre-commercial with zero operational units. The article's framing of SMRs as 'bleeding edge' obscures that full-scale deployment is 5-10+ years away, and regulatory/cost uncertainties remain unresolved. The AI power demand thesis is real but not unique to these three stocks.
If uranium supply actually normalizes as Kazakhstan and other producers ramp, or if AI data centers prove more efficient than assumed, the commodity tailwind evaporates and valuations compress sharply—especially for CCJ, which has already priced in much of the renaissance narrative.
"Constellation Energy offers the most immediate risk-adjusted exposure to AI power demand, whereas SMR developers like BWXT remain speculative long-term bets prone to significant regulatory and capital expenditure risk."
The nuclear renaissance is fundamentally a story of supply-demand mismatch, but investors must distinguish between commodity exposure and infrastructure leverage. Cameco (CCJ) is a pure-play on uranium prices, which are notoriously volatile and subject to geopolitical supply shocks. Constellation Energy (CEG) is the most viable play for immediate AI-driven data center demand, given its existing grid-connected capacity. However, the market is currently pricing in perfection for SMRs. BWX Technologies (BWXT) is priced for high growth, yet SMR commercialization faces massive regulatory and cost-overrun hurdles that the article ignores. Investors should focus on utilities with existing baseload capacity rather than speculative hardware developers until the SMR regulatory framework stabilizes.
If SMR technology fails to reach commercial feasibility, companies like BWXT will face massive valuation compression while uranium miners could see prices collapse if global public sentiment shifts against nuclear expansion.
"This bullish shortlist understates that nuclear-investment returns are primarily driven by contracting/price cycles and project execution/permit timelines, not just thematic growth and recent EPS momentum."
The article’s “nuclear renaissance” framing is directionally right, but it cherry-picks metrics that may not reflect valuation or execution risk. CCJ’s uranium supply/demand balance can swing with reactor build delays and production decisions; miners’ EPS volatility often tracks contract pricing, not long-term renewals. CEG benefits from capacity/dispatch economics, yet regulatory, licensing, and refueling timing can dominate returns more than AI demand narratives. BWXT’s SMR upside hinges on orders, financing, and regulatory approval—none of which are evidenced by “revenue/EPS growth” alone. Net: long duration tailwinds, but stock outcomes depend on project delivery and pricing power.
The strongest pushback is that long-duration nuclear policy tailwinds (DOE goals, national security incentives) plus existing reactor operators and uranium contracting could still re-rate these names even if specific execution risk materializes later than hoped.
"Cameco's high-grade mines and Westinghouse JV provide cost advantages and downstream exposure, making it the most resilient play in a uranium-constrained nuclear buildout."
Nuclear's renaissance is credible, fueled by AI's baseload power demands (e.g., Constellation's Microsoft deal for Three Mile Island restart) and DOE's tripling goal by mid-century. Cameco (CCJ) stands out with 15% global uranium output from ultra-high-grade mines (McArthur River 6.48%, Cigar Lake 16.33%), driving 11% revenue growth, 114% EPS surge, 16.93% margins, and 0.14 D/E in 2025—positioning it for supply squeezes as 75 reactors build. Constellation (CEG) leverages 21/94 U.S. reactors with 8.34% revenue growth and growing 0.57% yield dividend. BWXT's SMRs (BANR) offer upside via Navy expertise but remain pre-commercial. Article omits uranium contract lags behind spot strength and Western regulatory delays versus China's buildout.
Uranium prices are volatile with Kazakhstan's Kazatomprom (larger producer) potentially ramping output to flood supply, capping CCJ upside; SMRs like BWXT's face repeated timeline slips and cost overruns as seen historically in nuclear projects.
"Kazatomprom supply expansion is the overlooked downside for CCJ that could dwarf AI demand upside if uranium reverts to $60-70/lb range."
Grok cites Kazatomprom as a supply risk, but undersells it. Kazatomprom controls ~20% of global production and has explicitly stated capacity expansion plans through 2030. If they execute even 70% of announced capex, uranium spot could face structural downward pressure regardless of reactor build timelines. Nobody's quantified CCJ's breakeven or margin compression at $60/lb vs. current $90/lb assumptions. That's the real valuation cliff, not SMR timeline slips.
"Cameco's long-term contract structure acts as a financial buffer against spot uranium price fluctuations, insulating them from the 'valuation cliff' Claude describes."
Claude, your focus on the 'valuation cliff' at $60/lb is correct, but you're ignoring the contracting cycle. CCJ doesn't sell at spot; they utilize long-term contracts with price floors and escalators. The real risk isn't spot price volatility—it's the 'utility lock-in' effect where Western utilities prioritize security of supply over spot price arbitrage. If Kazatomprom ramps, utilities simply diversify away from them to mitigate geopolitical risk, keeping CCJ’s contract book shielded from pure spot-market crashes.
"CCJ’s downside may be more about contract lag/coverage than spot falling, so the timing of realized price deterioration is the critical uncertainty."
Claude’s “valuation cliff” framing is strong, but his implied link from Kazatomprom ramp to CCJ margin compression assumes CCJ’s realized price will fall toward spot quickly. That’s not automatic; CCJ’s economics depend on contract terms, indexation lag, and existing contract coverage. The panel didn’t stress-test contract duration/coverage vs expected spot declines. If realized prices stay elevated for years, the “cliff” could be pushed out or softened—timing is the key variable.
"CCJ's contract protection is partial and rolling, exposing margins to spot declines via renewals."
Gemini and ChatGPT overstate CCJ's contract shield: ~40% of 2025-2029 production is spot-exposed or market-related, per Cameco's disclosures, with 20%+ renewing yearly. Sustained $60/lb spot forces new contracts lower, eroding realized prices by 2027 regardless of 'utility lock-in.' That's the margin compression vector nobody quantified—17% today vs. 12% breakeven.
Panel Verdict
No ConsensusThe panelists agreed that the 'nuclear renaissance' is credible, driven by AI's baseload power demands and DOE's goals, but they differed on the specific stocks' risks and opportunities.
Constellation's (CEG) existing grid-connected capacity and potential for AI-driven data center demand.
Margin compression for Cameco (CCJ) due to spot price volatility and potential supply increase from Kazatomprom.